ReviewThe American journal of pathology1999
The tauopathies: toward an experimental animal model.
Review in The American journal of pathology, 1999. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed.
- Comparison of Common and Disease-Specific Post-translational Modifications of Pathological Tau Associated With a Wide Range of Tauopathies.Frontiers in neuroscience · 2020Article
- Bidirectional relationship between sleep and Alzheimer's disease: role of amyloid, tau, and other factors.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2020Review
- Reconsideration of Amyloid Hypothesis and Tau Hypothesis in Alzheimer's Disease.Frontiers in neuroscience · 2018Review
- Molecular Mechanisms in the Pathogenesis of Alzheimer's disease and Tauopathies-Prion-Like Seeded Aggregation and Phosphorylation.Biomolecules · 2016Review
- Tau oligomers as potential targets for Alzheimer's diagnosis and novel drugs.Frontiers in neurology · 2013Review
- Understanding the kinetic roles of the inducer heparin and of rod-like protofibrils during amyloid fibril formation by Tau protein.The Journal of biological chemistry · 2011Article
- The role of tau in Alzheimer's disease and related disorders.CNS neuroscience & therapeutics · 2011Review
- Article
- Neurofibrillary and neurodegenerative pathology in APP-transgenic mice injected with AAV2-mutant TAU: neuroprotective effects of Cerebrolysin.Acta neuropathologica · 2009Article
- Pin1 has opposite effects on wild-type and P301L tau stability and tauopathy.The Journal of clinical investigation · 2008Article
- Quantitative proteomics identifies surfactant-resistant alpha-synuclein in cerebral cortex of Parkinsonism-dementia complex of Guam but not Alzheimer's disease or progressive supranuclear palsy.The American journal of pathology · 2007Article
- The tau N279K exon 10 splicing mutation recapitulates frontotemporal dementia and parkinsonism linked to chromosome 17 tauopathy in a mouse model.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2007Article
- Age-related amyloid beta deposition in transgenic mice overexpressing both Alzheimer mutant presenilin 1 and amyloid beta precursor protein Swedish mutant is not associated with global neuronal loss.The American journal of pathology · 2000Article
- Alzheimer-like neurodegeneration in aged antinerve growth factor transgenic mice.Proceedings of the National Academy of Sciences of the United States of America · 2000Article
- Transgenic models of tauopathies and synucleinopathies.Brain pathology (Zurich, Switzerland) · 1999Review
- Filamentous nerve cell inclusions in neurodegenerative diseases: tauopathies and alpha-synucleinopathies.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 1999Review
Corrections and comments
- Comment on
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.